Cristina Lavilla Olleros

ORCID: 0000-0002-3537-8607
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Gastrointestinal Tumor Research and Treatment
  • Healthcare Systems and Technology
  • COVID-19 and healthcare impacts
  • Autoimmune Bullous Skin Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Comparative International Legal Studies
  • Archaeological and Historical Studies
  • Cardiac pacing and defibrillation studies
  • Lymphadenopathy Diagnosis and Analysis
  • Systemic Lupus Erythematosus Research
  • Galician and Iberian cultural studies
  • Immunodeficiency and Autoimmune Disorders
  • Biomedical Research and Pathophysiology
  • Inflammasome and immune disorders
  • Cancer Immunotherapy and Biomarkers
  • Medical research and treatments
  • Drug-Induced Adverse Reactions
  • Eosinophilic Esophagitis
  • Employment, Labor, and Gender Studies
  • Cardiac Imaging and Diagnostics
  • HIV/AIDS oral health manifestations
  • Skin Diseases and Diabetes

Hospital General Universitario Gregorio Marañón
2018-2025

University of Pisa
2018

BioCruces Health research Institute
2018

University of the Basque Country
2018

Hôpital Cochin
2018

Assistance Publique – Hôpitaux de Paris
2018

Abstract Some patients with COVID-19 pneumonia develop an associated cytokine storm syndrome that aggravates the pulmonary disease. These may benefit of anti-inflammatory treatment. The role colchicine in hospitalized and established hyperinflammation remains unexplored. In a prospective, randomized controlled, observer-blinded endpoint, investigator-initiated trial, 240 were randomly allocated to receive oral or not. primary efficacy outcome measure was composite non-invasive mechanical...

10.1038/s41598-022-13424-6 article EN cc-by Scientific Reports 2022-06-02

To analyse the real-life practice on use of Tacrolimus (TAC) in patients with systemic lupus erythematosus (SLE) from three European SLE referral centres.Adult regularly followed at centres were included. Demographics, cumulative organ involvement, treatment history, Systemic Lupus Disease Activity Index (SLEDAI), laboratory features and physician's judgement collected baseline 3-6-12 months after starting TAC.29 included (89% female, mean age 38±9 years). Ethnicity was predominantly...

10.1136/lupus-2018-000274 article EN cc-by-nc Lupus Science & Medicine 2018-11-01
Francesç Formiga Manuel Rubio‐Rivas José María Mora‐Luján Samara Campos Escudero Rosa Fernandez Madera Martinez and 95 more Manuel Méndez‐Bailón Pedro Durán‐del Campo Andrea Riaño Pérez Francisco-Javier García-Sánchez José N. Alcalá-Pedrajas Sergio Arnedo Hernández Almudena Hernández Milian Ana Latorre Díez Ricardo Gil Sánchez Ramón Boixeda Julio Vicente Begoña Cortés Rodríguez C. Pérez María Esther Guisado Espartero José López Castro Santiago Rodríguez Suárez José F. Varona Ricardo Gomez‐Huelgas José Manuel Ramos José Manuel Casas Rojo José Manuel Ramos Carlos Lumbreras Jesús Millán Núñez-Cortés Juan Miguel Antón Santos Ricardo Gómez‐Huelgas Xavier Corbella Francesç Formiga Narcı́s Homs Abelardo Montero José María Mora‐Luján Manuel Rubio‐Rivas Paloma Agudo de Blas Coral Arévalo Cañas Blanca Ayuso García José Bascuñana Morejón Samara Campos Escudero María Carnevali Frías Santiago Cossio Tejido Borja de Miguel Campo Carmen Díaz Pedroche Raquel Diaz Simón Ana García Reyne Laura Ibarra Veganzones Lucía de Jorge Huerta Antonio Lalueza Blanco Jaime Laureiro Gonzalo Jaime Lora-Tamayo Carlos Lumbreras Guillermo Maestro de la Calle Rodrigo Miranda Godoy Barbara Otero Perpiña Diana Paredes-Ruíz Marcos Sánchez Fernández Javier Tejada Montes H. Costa del Sol. Marbella Victoria Augustín Bandera Javier García Alegría Nicolás Jiménez-García Jairo Luque del Pino María Dolores Martín Escalante Francisco Navarro Romero Victoria Rodríguez Julián Olalla Laura Abarca Casas Álvaro Alejandre de Oña Rubén Alonso Beato Leyre Alonso Gonzalo Jaime Alonso Muñoz Crhistian‐Mario Oblitas Cristina Ausín García Marta Bacete Cebrián Jesús Baltasar Corral María Barrientos Guerrero Alejandro David Bendala Estrada María Calderón Moreno Paula Carrascosa Fernández Raquel Carrillo Sabela Castañeda Pérez Eva Cervilla Muñoz Agustín Diego Chacón Moreno Maria Carmen Cuenca Carvajal Sergio De los Santos Andrés Enríquez Gómez Eduardo Fernández Carracedo María Mercedes Ferreiro-Mazón Jenaro Francisco Galeano Valle A. Torres García Irene Garcia Fernandez-Bravo María Eugenia García Leoni María Gómez Antúnez Candela González San Narciso Anthony Alexander Gurjian Lorena Jiménez Ibáñez Cristina Lavilla Olleros Cristina Llamazares Mendo

Acetylsalicylic acid (ASA) is widely used in the treatment and prevention of cardiovascular disorders. Our objective to evaluate its possible protective role, not only mortality but also other aspects such as inflammation, symptomatic thrombosis, intensive care unit (ICU) admission hospitalized COVID-19 patients. We realized an observational retrospective cohort study 20,641 patients with pneumonia collected followed-up from Mar 1st, 2020 May 2021, nationwide Spanish SEMI-COVID-19 Registry....

10.1007/s11739-021-02870-1 article EN other-oa Internal and Emergency Medicine 2021-11-29
José Manuel Casas Rojo Juan Miguel Antón Santos Jesús Millán-Núñez-Cortés Ricardo Gómez‐Huelgas José Manuel Ramos and 95 more Manuel Rubio‐Rivas Miguel-Ángel Corrales-González Maria-Rosa Fernández-Madera-Martínez José-Luis Beato-Pérez Francisco Arnalich Cristina Gallego‐Lezaún Pablo Pérez‐Martínez Sonia Molinos‐Castro Yale Tung‐Chen Manuel Madrazo Manuel Méndez‐Bailón Daniel Monge-Monge Gema-María García-García Rosa García Fenoll N Gilabert Rebeca Fuerte-Martínez Marta Contreras-Sánchez Nicolás Rhyman Jorge Peris-García Carlos Lumbreras Ana Belén Barbero-Barrera Blanca Beamonte-Vela Coralia Bueno Charo Burón-Fernández Ruth Calderón-Hernáiz Irene Casado-López José Manuel Casas Rojo Andrés Cortés-Troncoso Pilar Cubo‐Romano F Déodati Alejandro Estrada-Santiago Gonzalo García-Casasola Sánchez Elena García Guijarro Francisco Javier García Sánchez Pilar García de la Torre Mayte de Guzmán García-Monge Davide Luordo María Mateos González José Antonio Melero-Bermejo Cruz Pastor-Valverde José Luis Pérez-Quero Fernando Roque-Rojas Lorea Roteta-García Elena Sierra-Gonzalo Francisco Javier Teigell-Muñoz Juan Vicente de la Sota Javier Villanueva-Martínez Laura Abarca Casas Álvaro Alejandre de Oña Rubén Alonso Beato Leyre Alonso Gonzalo Jaime Alonso Muñoz Crhistian‐Mario Oblitas Cristina Ausín García Marta Bacete Cebrián Jesús Baltasar Corral María Barrientos Guerrero Alejandro David Bendala Estrada María Calderón Moreno Paula Carrascosa Fernández Raquel Carrillo Sabela Castañeda Pérez Eva Cervilla Muñoz Agustín Diego Chacón Moreno Maria Carmen Cuenca Carvajal Sergio De los Santos Andrés Enríquez Gómez Eduardo Fernández Carracedo María Mercedes Ferreiro-Mazón Jenaro Francisco Galeano Valle Alejandra García‐García Irene Garcia Fernandez-Bravo María Eugenia García Leoni María Gómez Antúnez Candela González San Narciso Anthony Alexander Gurjian Lorena Jiménez Ibáñez Cristina Lavilla Olleros Cristina Llamazares Mendo Sara L. Garcia Víctor Mato Jimeno Clara Millán Nohales Jesús Millán Núñez-Cortés Sergio Moragón Ledesma Antonio Muiño Míguez Cecilia Muñoz Delgado Lucía Ordieres Ortega Susana Pardo Sánchez Alejandro Parra Virto María Teresa Pérez Sanz Blanca Pinilla Llorente Sandra Piqueras Ruiz Guillermo Soria Fernández‐Llamazares María Toledano Macías Neera Toledo Samaniego

Abstract In 2020, the COVID-19 pandemic followed a two-wave pattern in most countries. Hospital admission for one wave or another could have affected mortality, especially among older persons. The objective of this study was to evaluate whether patients during different waves, before SARS-CoV-2 vaccination available, associated with mortality. We compared mortality rates hospitalized 2020 (first wave) and after (second July 7, included SEMI-COVID-19 Registry, large, multicenter,...

10.1038/s41598-023-42735-5 article EN cc-by Scientific Reports 2023-10-18

To describe the impact of different doses corticosteroids on evolution patients with COVID-19 pneumonia, based potential benefit non-genomic mechanism these drugs at higher doses.Observational study using data collected from SEMI-COVID-19 Registry. We evaluated epidemiological, radiological and analytical scenario between treated megadoses therapy vs low-dose development complications. The primary endpoint was all-cause in-hospital mortality according to use megadoses.Of a total 14,921...

10.1371/journal.pone.0261711 article EN cc-by PLoS ONE 2022-01-21

Introducción: Desde que se inició la pandemia por el SARS-CoV-2, han descrito numerosos casos de síndrome Guillain-Barré secundario a COVID-19. Su presentación típica es triada parestesias, debilidad muscular ascendente y arreflexia, aunque hay diversas variantes regionales como diplejía facial.
 Presentación del caso: Mujer 35 años que, dos semanas después un contacto estrecho con caso confirmado COVID-19, ingresa miopericarditis probablemente viral, estudio autoinmunidad negativo,...

10.31053/1853.0605.v78.n4.32392 article ES cc-by-nc Revista de la Facultad de Ciencias Médicas de Córdoba 2021-12-28
Coming Soon ...